Publication Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy Joseph P, Ponnaiya J, Das M, et al. Indian journal of leprosy. 2016; Download PDF
Publication Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. Legendre DP, Muzny C, Swiatlo E. Pharmacotherapy Publications. Pharmacotherapy. 2012; 32 (1) : 27-37.
Publication Newer drugs in leprosy. Grosset J H. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 2001; 69 (2 Suppl) : S14-8. Download PDF
Publication Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice. Consigny S, Bentoucha A, Bonnafous P, et al. Antimicrobial agents and chemotherapy. 2000; 44 (10) : 2919-21. Download PDF
Publication Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy. Ji B, Grosset J. Leprosy review. 2000; Download PDF
